HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

ANGO

AngioDynamics, Inc. (NASDAQ)

Healthcare — Medical Instruments & Supplies

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

None 4 analysts
$13.82
$-0.40 (-2.81%)
Target: $18.00 (30.2%)
Sign in to add ANGO to a watchlist or set price alerts.

Price History

Fundamentals

Market Cap$540.45M
P/E Ratio (TTM)-
Forward P/E-59.45
EPS (TTM)$-0.76
Dividend Yield-
Profit Margin-10.01%
Revenue Growth-
ROE-
Debt/Equity-
Recommendation None
Analyst Target$18.00
Analysts4
Indexes NASDAQ

Technical Indicators

RSI (14)59.3
Beta0.36
SMA 20-
SMA 40-
52-Week High-
52-Week Low-
50-Day Avg-
200-Day Avg-
Avg Volume392.6K
Volume394.2K

Performance Analysis

NEUTRAL

ANGO presents a mixed picture with both positive and negative indicators.

+ RSI at 59.3 shows positive momentum.
- Operating at a loss with -10.0% margin.
~ Wall Street consensus is "none" from 4 analysts.
+ Average analyst target of $18.00 implies 30.2% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 01, 2026 11:46 UTC

Back to Screener Export Report